T3d
Benefits may vary, and results in the general population on CV risk and mortality are still
controversial.
Overall, the results of recent studies have been mixed results. Different study populations,
end points and dosing may account for the lack of clarity. #NephJC
My two little fish say hello… #NephJC
We see it. Hello!!! #NephJC
Throwing a fish to everyone… #NephJC
Hi. It’s been a long time… glad to be back to #nephJC
Hector Madariaga. Transplant kidney doc. Cambridge, MA
I don’t prescribe IT, but some of my patients are already on it. I have been calling it a non-essential medication, but maybe I should start prescribing fish oil!!! #NephJC
1/10
Last #NephJC we discussed the ORIGIN 3 trial which investigated the use of Atacicept in IgAN #TenPostNephJC
Read the article 👇
www.nejm.org/doi/10....
New Trump EO increases fee from $1,000 to $100,000 per year for H1B visas?? Aimed at tech companies hiring cheaper trained people.
However, this is going to be extremely disruptive to residency training programs and hospitals. Hope someone clues him in.
Comments in the NYT are also very interesting. One that caught my attention mentioned that current system is biased in favor of procuring organs in patients who are declared DCD. The cost of having no one prematurely referred for organ donation would be eliminating cadaveric donations altogether.
The NYT piece is a very sensational article & not well balanced. I believe it has caused more harm than good. I don’t blame people for criticizing the OPTN and OPOs—given all the issues you’ve mentioned, they deserve it—but the current system, albeit not perfect, works in 99% of cases. Should be 💯
A response to the NYT article about organ donation, from Tom Mone, a former President and Chief Executive Officer of the OneLegacy OPO
sidandt.org/tom-mones-re...
Kidney transplant in patients with C3 glomerulopathy
academic.oup.com/ckj/article/...
My birthday wishlist… 🔥
I recently attended the Student National Medical Association’s AMEC 2025 conference,where we engaged w/med students/residents to promote the field of nephrology,mentoring opportunities, educational programs & health policy initiatives. It was a pleasure to work with the ASN staff
Oh wow… this has rarely been my practice but very interesting! #NephJC
T1f: #NephJC
3-Year Survival Outcomes
Pts who continued metformin ≥6 months after reaching CKD stage 4 demonstrated significantly higher survival (70.3%; 95% CI, 67.9–72.8) compared to those who discontinued early (63.4%; 95% CI, 60.5–66.5)
💡6.9 percentage-point difference (95% CI, 3.2–10.6)
Not sure if relevant but I love Scottish terriers… #NephJC
What if CKD-EPI GFR of 35 mL/min and MDRD GFR of 25 mL/min ?
Take average?
Add GFRcys of 30 mL/min…
#NephJC
I use metformin in kidney transplant recipients as a first line agent in post-transplant diabetes when eGFR >30 😬
Then a flozin. Then a GLP-1 RA
All good 👍
#NephJC
Checking some Greek art at the Museum of Fine Arts in Boston, when suddenly…. Mr Bean?!
How much milk foam is too much?
Diabetic Kidney Disease (DKD) ca. 2025 from @elsevierconnect.bsky.social @annagaddy.bsky.social @hecmagsmd.bsky.social @doctorgates.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/39753456/
Today, I had the honor of participating in this amazing panel to talk about organ donation, particularly those barriers that affect the Hispanic community. It was a privilege to listen to my co-panelists share their stories about their journeys with organ donation
And don’t hold Flozins before TAVI
The American Society of Transplantation (AST) stands in support of their members who face immigration challenges 🙌
Subcutaneous Ofatumumab in Recurrent Focal Segmental Glomerulosclerosis Post Kidney Transplantation
academic.oup.com/ckj/advance-...
So, what’s up with the all those blood clots found in NBA players.
Is it the NSAIDs mostly?
apnews.com/article/bloo...
First time watching the ISU World Skating Champsionship in Boston, MA. Here’s the new champ: Alysa Liu 🇺🇸
#Figureskating #Worldfigure
